chr7-151066534-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_003040.4(SLC4A2):c.596C>T(p.Ala199Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000805 in 1,503,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_003040.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC4A2 | NM_003040.4 | c.596C>T | p.Ala199Val | missense_variant | 6/23 | ENST00000413384.7 | NP_003031.3 | |
SLC4A2 | NM_001199692.3 | c.596C>T | p.Ala199Val | missense_variant | 6/23 | NP_001186621.1 | ||
SLC4A2 | NM_001199693.1 | c.569C>T | p.Ala190Val | missense_variant | 5/22 | NP_001186622.1 | ||
SLC4A2 | NM_001199694.2 | c.554C>T | p.Ala185Val | missense_variant | 5/22 | NP_001186623.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC4A2 | ENST00000413384.7 | c.596C>T | p.Ala199Val | missense_variant | 6/23 | 1 | NM_003040.4 | ENSP00000405600 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000148 AC: 21AN: 141506Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000540 AC: 7AN: 129532Hom.: 0 AF XY: 0.0000439 AC XY: 3AN XY: 68370
GnomAD4 exome AF: 0.0000734 AC: 100AN: 1362154Hom.: 0 Cov.: 44 AF XY: 0.0000760 AC XY: 51AN XY: 670896
GnomAD4 genome AF: 0.000148 AC: 21AN: 141616Hom.: 0 Cov.: 34 AF XY: 0.000158 AC XY: 11AN XY: 69458
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at